Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis

Overview of attention for article published in Drug Design, Development and Therapy, May 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 115 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 31 publications that cite this research output.

31

The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.

Alopecia associated with dimethyl fumarate treatment for multiple sclerosis

Article in Wiener Medizinische Wochenschrift (March 2023)

New and Old Horizons for an Ancient Drug: Pharmacokinetics, Pharmacodynamics, and Clinical Perspectives of Dimethyl Fumarate

Article in Pharmaceutics (December 2022)

Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study

Article in Antioxidants (May 2022)